Cancer cell nutrient pathway mechanism discovered
Researchers have discovered the mechanism behind a gateway into cells for glutamine, illuminating potential ways to prevent cancer cells from getting nutrients.
List view / Grid view
Researchers have discovered the mechanism behind a gateway into cells for glutamine, illuminating potential ways to prevent cancer cells from getting nutrients.
Researchers have newly found that protein CD24 acts as a defensive signal and is used by cancer cells to protect themselves.
New study sheds light on how the TP53 gene becomes mutated and how those mutations can help predict clinical outlooks for cancer.
Researchers have identified a key process behind senescence, or why cells age, which could be used to improve treatments for cancer.
Scientists have created the first completely artificial protein switch that can be ‘programmed’ to modify gene expression.
Researchers have found that fat cells transfer cytokines to melanoma cells, which transforms them into aggressive tumours, indicating a drug target for the condition.
A new study has found a novel way to target an enzyme involved in cancer growth, which could inform therapeutics for the condition.
Researchers have identified a protein that plays a role in promoting blood cancer and have successfully used a novel compound to inhibit it, reducing tumour growth.
A protein has been discovered as key for effective chemotherapy, meaning improved treatments for chemotherapy resistance can be developed.
A study has identified a gene key in the spread of cancer, which could point to improving treatments for the condition, say the researchers.
A research team has developed a vaccine that advances anti-tumour T-cell populations and allows the cells to invade solid tumours.
New study shows the ability of CD8+ cytotoxic T cells to penetrate a large target, which opens avenues to destroy solid cancers.
The use of models is a key feature of preclinical studies and in recent months there have been several new advancements in this area. This article investigates five of the latest developments.
Researchers have used machine learning to discover that the two most widespread DNA structures cause genome mutations that lead to cancer.
From the world’s flagship neutron science facility, Institut Laue-Langevin (ILL), Matthew Blakeley shares insights into how they are harnessing the power of neutrons to aid their search for new cancer treatments.